536 related articles for article (PubMed ID: 26633182)
1. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
2. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma.
Patel M; Winston CB; Marr BP; Carvajal RD; Schwartz GK; Wolchok J; Busam K; Abramson DH
Arch Ophthalmol; 2011 Dec; 129(12):1576-82. PubMed ID: 22159677
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Ultrasonography Compared With Computed Tomography and Magnetic Resonance Imaging at Diagnosis of Metastatic Uveal Melanoma.
Rantala ES; Peltola E; Helminen H; Hernberg M; Kivelä TT
Am J Ophthalmol; 2020 Aug; 216():156-164. PubMed ID: 32278769
[TBL] [Abstract][Full Text] [Related]
4. Risk-stratified systemic surveillance in uveal melanoma.
Davanzo JM; Binkley EM; Bena JF; Singh AD
Br J Ophthalmol; 2019 Dec; 103(12):1868-1871. PubMed ID: 30705044
[TBL] [Abstract][Full Text] [Related]
5. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma.
Feinstein EG; Marr BP; Winston CB; Abramson DH
Arch Ophthalmol; 2010 Mar; 128(3):319-23. PubMed ID: 20212202
[TBL] [Abstract][Full Text] [Related]
6. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
7. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
Kim IK; Lane AM; Gragoudas ES
Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
[TBL] [Abstract][Full Text] [Related]
8. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
9. Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization.
Dayani PN; Gould JE; Brown DB; Sharma KV; Linette GP; Harbour JW
Arch Ophthalmol; 2009 May; 127(5):628-32. PubMed ID: 19433711
[TBL] [Abstract][Full Text] [Related]
10. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
[TBL] [Abstract][Full Text] [Related]
11. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients.
Piperno-Neumann S; Servois V; Mariani P; Plancher C; Lévy-Gabriel C; Lumbroso-Le Rouic L; Couturier J; Asselain B; Desjardins L; Cassoux N
J Fr Ophtalmol; 2015 Jun; 38(6):526-34. PubMed ID: 25978872
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
Klingenstein A; Haug AR; Zech CJ; Schaller UC
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
[TBL] [Abstract][Full Text] [Related]
14. Liver function tests in metastatic uveal melanoma.
Kaiserman I; Amer R; Pe'er J
Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
[TBL] [Abstract][Full Text] [Related]
15. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
[TBL] [Abstract][Full Text] [Related]
16. Fotemustine chemoembolization of hepatic metastases from uveal melanoma: a retrospective single-center analysis.
Edelhauser G; Schicher N; Berzaczy D; Beitzke D; Höeller C; Lammer J; Funovics M
AJR Am J Roentgenol; 2012 Dec; 199(6):1387-92. PubMed ID: 23169735
[TBL] [Abstract][Full Text] [Related]
17. Liver function testing is not helpful for early diagnosis of metastatic uveal melanoma.
Mouriaux F; Diorio C; Bergeron D; Berchi C; Rousseau A
Ophthalmology; 2012 Aug; 119(8):1590-5. PubMed ID: 22683062
[TBL] [Abstract][Full Text] [Related]
18. Treatment of liver metastases from uveal melanoma.
Rivoire M; Kodjikian L; Baldo S; Kaemmerlen P; Négrier S; Grange JD
Ann Surg Oncol; 2005 Jun; 12(6):422-8. PubMed ID: 15886904
[TBL] [Abstract][Full Text] [Related]
19. Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma.
Francis JH; Catalanotti F; Landa J; Barker CA; Shoushtari AN; Abramson DH
Br J Ophthalmol; 2019 Sep; 103(9):1266-1271. PubMed ID: 30381389
[TBL] [Abstract][Full Text] [Related]
20. Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.
Eldredge-Hindy H; Ohri N; Anne PR; Eschelman D; Gonsalves C; Intenzo C; Bar-Ad V; Dicker A; Doyle L; Li J; Sato T
Am J Clin Oncol; 2016 Apr; 39(2):189-95. PubMed ID: 24441583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
